FMP
RavenQuest BioMed Inc.
RVVQF
PNK
RavenQuest BioMed Inc., a cannabis company, focuses on the cannabis production, management services and consulting, and specialized research and development activities. The company operates in two segments, Consulting Business, and Cultivation and Sale of Medical Cannabis. It offers its products under the Lore Cannabis and Bloomera brand names. The company was formerly known as Ravencrest Resources Inc. and changed its name to RavenQuest BioMed Inc. in September 2017. RavenQuest BioMed Inc. was incorporated in 1987 and is based in Vancouver, Canada.
0.00001 USD
0.000009 (90%)
Operating Data
Year
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Revenue
-
-
-
81.36k
910.09k
1.14M
1.42M
1.78M
2.22M
2.78M
Revenue %
-
-
-
-
1.02k
25
25
25
25
Ebitda
-45.14k
-55.1k
-58.99k
-464.43k
-11.08M
227.52k
284.4k
355.51k
444.38k
555.48k
Ebitda %
100
100
100
-570.82
-1.22k
20
20
20
20
Ebit
-63.25k
-59.88k
-75.51k
-464.64k
-12.44M
227.52k
284.4k
355.51k
444.38k
555.48k
Ebit %
100
100
100
-571.08
-1.37k
20
20
20
20
Depreciation
18.1k
4.78k
16.52k
207.11
1.36M
910.67k
1.14M
1.42M
1.78M
2.22M
Depreciation %
100
100
100
0.25
149.71
80.05
80.05
80.05
80.05
Balance Sheet
Year
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Total Cash
6.8k
1.11k
437.4
2.45M
262.74k
975.78k
1.22M
1.52M
1.91M
2.38M
Total Cash %
100
100
100
3.01k
28.87
85.77
85.77
85.77
85.77
Receivables
-
-
-
133.24k
728.62k
1.09M
1.37M
1.71M
2.13M
2.67M
Receivables %
100
100
100
163.77
80.06
96.01
96.01
96.01
96.01
Inventories
-
-
-
-
644.4k
843.67k
1.05M
1.32M
1.65M
2.06M
Inventories %
100
100
100
-
70.81
74.16
74.16
74.16
74.16
Payable
221.87k
235.26k
-
-
1.49M
910.09k
1.14M
1.42M
1.78M
2.22M
Payable %
100
100
100
-
163.62
80
80
80
80
Cap Ex
-
-
-
-689.41
-8.88M
-229.45k
-286.81k
-358.52k
-448.15k
-560.18k
Cap Ex %
100
100
100
-0.85
-975.54
-20.17
-20.17
-20.17
-20.17
Weighted Average Cost Of Capital
Price
0
Beta
Diluted Shares Outstanding
91.03M
Costof Debt
14.36
Tax Rate
After Tax Cost Of Debt
14.09
Risk Free Rate
Market Risk Premium
Cost Of Equity
Total Debt
9.6M
Total Equity
910.34
Total Capital
9.6M
Debt Weighting
99.99
Equity Weighting
0.01
Wacc
14.3
Build Up Free Cash Flow
Year
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Revenue
-
-
-
81.36k
910.09k
1.14M
1.42M
1.78M
2.22M
2.78M
Ebitda
-45.14k
-55.1k
-58.99k
-464.43k
-11.08M
227.52k
284.4k
355.51k
444.38k
555.48k
Ebit
-63.25k
-59.88k
-75.51k
-464.64k
-12.44M
227.52k
284.4k
355.51k
444.38k
555.48k
Tax Rate
1.86
1.86
1.86
1.86
1.86
1.86
1.86
1.86
1.86
1.86
Ebiat
-63.25k
-59.88k
-75.51k
-464.63k
-12.21M
226.68k
283.34k
354.18k
442.73k
553.41k
Depreciation
18.1k
4.78k
16.52k
207.11
1.36M
910.67k
1.14M
1.42M
1.78M
2.22M
Receivables
-
-
-
133.24k
728.62k
1.09M
1.37M
1.71M
2.13M
2.67M
Inventories
-
-
-
-
644.4k
843.67k
1.05M
1.32M
1.65M
2.06M
Payable
221.87k
235.26k
-
-
1.49M
910.09k
1.14M
1.42M
1.78M
2.22M
Cap Ex
-
-
-
-689.41
-8.88M
-229.45k
-286.81k
-358.52k
-448.15k
-560.18k
Ufcf
176.73k
-41.71k
-294.25k
-598.35k
-19.47M
-234.03k
878.42k
1.1M
1.37M
1.72M
Wacc
14.3
14.3
14.3
14.3
14.3
Pv Ufcf
-204.75k
672.37k
735.31k
804.15k
879.43k
Sum Pv Ufcf
2.89M
Terminal Value
Growth In Perpetuity Method
Long Term Growth Rate
Wacc
14.3
Free Cash Flow T1
1.75M
Terminal Value
14.22M
Present Terminal Value
7.29M
Intrinsic Value
Enterprise Value
10.17M
Net Debt
9.34M
Equity Value
835.7k
Diluted Shares Outstanding
91.03M
Equity Value Per Share
0.01
Projected DCF
0.00918013 0.999%
